AIM IMMUNOTECH INC. Earnings Per Share (Basic)
AIM IMMUNOTECH INC. (AIM) reported Earnings Per Share (Basic) of -$0.43 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-07
- AIM IMMUNOTECH INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.43.
- AIM IMMUNOTECH INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.69.
- AIM IMMUNOTECH INC. earnings per share, basic for the quarter ending 2025-12-31 was -$1.45.
- AIM IMMUNOTECH INC. earnings per share, basic for the quarter ending 2025-09-30 was $1.57.
- AIM IMMUNOTECH INC. earnings per share, basic for fiscal 2025 was -$8.62.
- AIM IMMUNOTECH INC. earnings per share, basic for fiscal 2024 was -$30.92.
- AIM IMMUNOTECH INC. earnings per share, basic for fiscal 2023 was -$0.60.
- AIM IMMUNOTECH INC. earnings per share, basic for fiscal 2022 was -$0.40.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.43 10-Q · filed 2026-08-07 | -$0.96 10-Q · filed 2026-08-07 | -$1.35 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$2.16 derived: net income ÷ weighted average shares · filed 2026-08-07 | ||||
| 2026-03-31 | -$0.69 10-Q · filed 2026-05-15 | -$1.99 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$3.37 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$5.26 derived: net income ÷ weighted average shares · filed 2026-08-07 | ||||
| 2025-12-31 | -$1.45 derived: net income ÷ weighted average shares · filed 2026-03-27 | -$2.99 derived: net income ÷ weighted average shares · filed 2026-03-27 | -$5.36 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$8.62 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | $1.57 10-Q · filed 2025-11-17 | -$4.26 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$8.18 10-Q · filed 2025-11-17 | -$15.01 derived: net income ÷ weighted average shares · filed 2026-08-07 | ||||
| 2025-06-30 | -$3.68 10-Q · filed 2026-08-07 | -$8.88 10-Q · filed 2026-08-07 | -$17.79 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$24.13 derived: net income ÷ weighted average shares · filed 2026-08-07 | ||||
| 2025-03-31 | -$0.05 10-Q · filed 2026-05-15 | -$14.40 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$20.89 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$24.84 derived: net income ÷ weighted average shares · filed 2026-08-07 | ||||
| 2024-12-31 | -$9.32 derived: net income ÷ weighted average shares · filed 2026-03-27 | -$15.89 derived: net income ÷ weighted average shares · filed 2026-03-27 | -$19.77 derived: net income ÷ weighted average shares · filed 2026-03-27 | -$30.92 10-K · filed 2026-03-27 | -$0.31 10-K · filed 2025-03-27 | |||
| 2024-09-30 | -$6.00 10-Q · filed 2025-11-17 | -$0.06 10-Q · filed 2024-11-14 | -$10.02 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$21.00 10-Q · filed 2025-11-17 | -$0.21 10-Q · filed 2024-11-14 | -$0.96 derived: net income ÷ weighted average shares · filed 2025-11-17 | ||
| 2024-06-30 | -$3.00 10-Q · filed 2025-08-14 | -$0.03 10-Q · filed 2024-08-14 | -$15.00 10-Q · filed 2025-08-14 | -$0.15 10-Q · filed 2024-08-14 | -$0.61 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$0.76 derived: net income ÷ weighted average shares · filed 2025-11-17 | ||
| 2024-03-31 | -$0.12 10-Q · filed 2025-05-15 | -$0.37 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$0.53 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$0.64 derived: net income ÷ weighted average shares · filed 2025-11-17 | ||||
| 2023-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$0.42 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$0.52 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$0.60 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | -$0.16 10-Q · filed 2024-11-14 | -$0.26 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.34 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | -$0.10 10-Q · filed 2024-08-14 | -$0.18 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$0.08 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | -$0.40 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | -$0.13 10-Q · filed 2023-11-14 | -$0.31 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | -$0.10 10-Q · filed 2023-08-14 | -$0.18 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | -$0.08 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | -$0.40 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | -$0.08 10-Q · filed 2022-11-14 | -$0.28 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.12 10-Q · filed 2022-08-15 | -$0.20 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | -$0.08 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |